Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | HRH2 | P25021 | 4/20 | 0.41 |
| ▸ | SCN5A | Q14524 | 3/20 | 0.41 |
| ▸ | SCN2A | Q99250 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.39 |
| ▸ | HPGD | P15428 | 5/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9867011 | 0.95 | LMNA (0.43) | LMNASMN1; SMN2HRH2SCN5ASCN2A | |
| SCHEMBL9865910 | 0.94 | KMT2A (0.43) | LMNASMN1; SMN2HRH2SCN5ASCN2A | |
| SCHEMBL9866012 | 0.94 | LMNA (0.53) | LMNASMN1; SMN2SCN5ASCN2AALDH1A1 | |
| SCHEMBL9867640 | 0.93 | SCN5A (0.45) | LMNASMN1; SMN2HRH2SCN5ASCN2A | |
| SCHEMBL9867644 | 0.93 | SCN5A (0.45) | LMNASMN1; SMN2HRH2SCN5ASCN2A | |
| SCHEMBL7433583 | 0.93 | SMN1; SMN2 (0.41) | LMNASMN1; SMN2HRH2ALDH1A1HPGD | |
| SCHEMBL9865162 | 0.93 | GAA (0.44) | LMNASMN1; SMN2HRH2ALDH1A1HPGD | |
| SCHEMBL9866319 | 0.92 | ALDH1A1 (0.46) | LMNASMN1; SMN2SCN5ASCN2AALDH1A1 | |
| SCHEMBL9866151 | 0.91 | LMNA (0.39) | LMNASMN1; SMN2HRH2SCN5ASCN2A | |
| SCHEMBL9866425 | 0.90 | RAB9A (0.42) | LMNASMN1; SMN2HRH2ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5021431-A | H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion | HEUMANN PHARMA GMBH & CO. (DE) | 1991-06-04 | — | — | US | disclosed |
| EP-0199845-B1 | IMIDAZOLYLALKYLGUANIDIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | HEUMANN PHARMA GMBH & CO (DE) | 1990-08-01 | — | — | EP | disclosed |
| EP-0199845-A1 | Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them | HEUMANN PHARMA GMBH & CO (DE) | 1986-11-05 | — | — | EP | disclosed |